eMedicine Specialties > Physical Medicine and Rehabilitation > Peripheral Neuropathy

Alcoholic Neuropathy

Author: Scott R Laker, MD, Staff Physician, Department of Rehabilitation, University of Colorado Health Sciences Center
Coauthor(s): William J Sullivan, MD, Assistant Professor, Pain Medicine Fellowship Director, Director of Medical Student Education, Department of Physical Medicine and Rehabilitation, University of Colorado at Denver Health Sciences Center
Contributor Information and Disclosures

Updated: Sep 5, 2008

Introduction

Background

The development of peripheral neuropathy, specifically, the formation of primary axonal sensorimotor peripheral polyneuropathy, is a risk for persons who have consumed large quantities of alcoholic beverages over an extended period of time. Symptoms of alcoholic neuropathy, like those of many of the other axonal mixed polyneuropathies, manifest initially in the lower extremities and feet. Sensory symptoms (eg, numbness, paresthesias, dysesthesias, loss of vibration and position sense) generally manifest prior to motor symptoms (eg, weakness). However, patients may present with motor and sensory symptoms at initial presentation.

In most cases of alcoholic neuropathy, the onset of the polyneuropathy is insidious and prolonged, but some cases have been associated with acute, rapidly progressive onset. Symptoms seem to be associated with the lifetime consumption of alcohol, although exceptions are common. Severe cases of alcoholic neuropathy can lead to the development of symptoms in the proximal lower extremities and distal upper extremities.

Related eMedicine topics:
Alcohol and Substance Abuse Evaluation
Alcohol (Ethanol) Related Neuropathy
Alcoholism
Toxicity, Alcohols

Related Medscape topic:
Resource Center Addiction

Pathophysiology

Alcoholic neuropathy is a primary axonal neuropathy characterized by wallerian degeneration of the axons and a reduction in the myelination of neural fibers.1 Controversy surrounds the pathogenic role of alcohol in development of this neuropathy. Studies on rat models have indicated that alcohol does have a directly neurotoxic effect on spinal cord and neuronal organelles.2,3 Acetaldehyde, a metabolite of ethanol, has a direct neurotoxic effect. Ethanol also impairs axonal transport and disturbs cytoskeletal properties. A review of the human literature implicates nutritional deficiencies, most often thiamine deficiency, that are common in alcoholic patients, as the primary causative factor in the development of this neuropathy. Persons with alcoholism may consume smaller amounts of essential nutrients and vitamins and/orexhibitimpaired gastrointestinalabsorption of these nutrients secondary to the direct effects of alcohol.

Protein kinases A and C have also been implicated in the painful symptoms associated with alcoholic neuropathy.4  Symptoms also have an association with the metabotropic glutamate 5 (mGlu5) receptor in rat models.5

Thiamine, also known as the antiberiberi factor or antineuritic factor, is an essential vitamin in the metabolism of pyruvate and has a role in the health of the peripheral nervous system. Thiamine deficiency commonly is found in alcoholic patients, due to decreased absorption and hepatic depletion. Other studies have linked the direct toxic effects of alcohol on peripheral nerves with development of neuropathy. A combination of nutritional deficiency and direct toxicity probably is involved in the pathogenesis of alcoholic neuropathy, and these effects may be additive.6,7 Alcohol also has been implicated in the development of cardiac autonomic neuropathy (CAN) and various cranial neuropathies, including optic neuropathy and vagus neuropathy.

Pure alcoholic neuropathy is distinguishable from beriberi (thiamine deficiency). A histopathological review of sural nerve biopsy results revealed small-fiber axonal loss, myelin irregularities, and possibly neural regeneration in chronic cases.6,7 A Japanese study found an alcoholic dehydrogenase gene mutation that led to decreased alcohol metabolism and decreased sensory nerve action potentials in the affected group.8

Related eMedicine topic:
Nutritional Neuropathy

Frequency

United States

The true incidence of alcoholic neuropathy in the general population is unknown, and figures vary widely, depending on the definition of chronic alcoholism and the criteria used to classify and detect neuropathy. Using the criteria for alcoholism listed in the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV), studies employing clinical and electrodiagnostic criteria have estimated that neuropathy is present in 25-66% of defined "chronic alcoholics." The factors most directly associated with the development of alcoholic neuropathy include the duration and amount of total lifetime alcohol consumption.

Mortality/Morbidity

Chronic consumption of alcohol has been implicated in end-organ damage to multiple systems. Damaged structures include the brain (exhibited by development of Wernicke encephalopathy, Korsakoff psychosis, and cerebellar ataxia), heart (as in cardiac myopathy and autonomic neuropathy), pancreas, gallbladder, and liver (cirrhosis), as well as the peripheral nerves. Patients with multisystem damage as a result of alcohol consumption often die of cardiac or liver failure.

Children exposed to greater than 2 oz of alcohol per day in utero exhibit nerve conduction slowing and decreased compound muscle action potential (CMAP) amplitude in comparison with children with no prenatal exposure to alcohol.9

Race

Cultural and racial factors involved in the consumption of alcoholic beverages are beyond the scope of this article. The subject has not been well studied in terms of the development of alcoholic neuropathy. However, one noteworthy study suggested that the risk of developing peripheral neuropathy is higher in alcoholic patients whose parents had a history of alcoholism.10

Sex

Ammendola and colleagues conducted a study to assess differences between men and women in the development of alcoholic neuropathy.11 This study used the sural sensory nerve action potential (SNAP) amplitude (ie, nerve conduction study) as the variable measure to detect significant neuropathy in a population of males and females with chronic alcoholism. Although the study provided control for nutritional deficiencies, the female group with chronic alcoholism had a significantly lower sural SNAP amplitude compared with the male group with similar total lifetime dose of ethanol consumption (TLDEC). This study suggested that females may demonstrate increased sensitivity to the toxic effects of alcohol on peripheral nerves.

Age

Increased incidence of alcoholism occurs within the elderly population; however, discussion of this alarming trend is beyond the scope of this article. As mentioned previously, development of alcoholic neuropathy is associated with the duration and extent of total lifetime consumption of alcohol. Elderly persons, because of the natural diminution of postural reflexes and the nerve cell degeneration that occurs with advanced age, may be more at risk for the clinical problems associated with a peripheral neuropathy, such as frequent falls and loss of balance.

Clinical

History

Ascertaining the symptomatic history of a patient with alcoholic neuropathy is not specific for diagnosis. Pure alcoholic neuropathy is characterized by a progressive, sensory-dominant symptomatology. Interestingly, concomitant thiamine deficiency creates a much more variable presentation. A detailed history of alcohol use should be obtained from any patient presenting with symptoms of general neuropathy. Additionally, nutritional history and questioning regarding other neuropathy risk factors should be documented.

  • Patients with alcoholic neuropathy typically present with a history of alcoholism and an insidious onset of distal lower extremity paresthesias, dysesthesias, or weakness. The most common symptom seems to be burning dysesthesias in the feet and toes. Less commonly, patients present with a more rapid, acute onset of symptoms.
  • Patients also may have a history of gait ataxia and difficulty walking or a history of frequent falls.
  • In cases of more advanced presentation, patients may report upper extremity symptoms.

Physical

Classic physical examination findings associated with alcoholic neuropathy may include the following:

  • Diminished sensation to vibration or pinprick stimulation in a "stocking-to-glove" distribution
  • Thermal and proprioceptive sensation abnormalities
  • Muscle stretch reflexes, especially of the gastrocnemius-soleus muscle complex
  • Weakness of ankle/toe dorsiflexion and/or ankle plantar flexion strength
  • Intrinsic atrophy of foot muscles in advanced cases
  • Gait ataxia with a widened base of support or bilateral foot drop

Evidence of other alcohol-related, end-organ damage also may be observed on physical examination.

Causes

Excess alcohol consumption causes alcoholic neuropathy. As previously stated, further studies must be performed to determine genetic influences on this disorder. 

More on Alcoholic Neuropathy

Overview: Alcoholic Neuropathy
Differential Diagnoses & Workup: Alcoholic Neuropathy
Treatment & Medication: Alcoholic Neuropathy
Follow-up: Alcoholic Neuropathy
References

References

  1. Yerdelen D, Koc F, Uysal H. Strength-duration properties of sensory and motor axons in alcoholic polyneuropathy. Neurol Res. May 16 2008;[Medline].

  2. Corsetti G, Rezzani R, Rodella L, et al. Ultrastructural study of the alterations in spinal ganglion cells of rats chronically fed on ethanol. Ultrastruct Pathol. Jul-Aug 1998;22(4):309-19. [Medline].

  3. Narita M, Miyoshi K, Narita M, et al. Involvement of microglia in the ethanol-induced neuropathic pain-like state in the rat. Neurosci Lett. Feb 27 2007;414(1):21-5. [Medline].

  4. Chen X, Levine JD. Mechanically-evoked C-fiber activity in painful alcohol and AIDS therapy neuropathy in the rat. Mol Pain. 2007;3:5. [Medline][Full Text].

  5. Miyoshi K, Narita M, Takatsu M, et al. mGlu5 receptor and protein kinase C implicated in the development and induction of neuropathic pain following chronic ethanol consumption. Eur J Pharmacol. May 21 2007;562(3):208-11. [Medline].

  6. Koike H, Iijima M, Sugiura M, et al. Alcoholic neuropathy is clinicopathologically distinct from thiamine-deficiency neuropathy. Ann Neurol. Jul 2003;54(1):19-29. [Medline].

  7. Koike H, Mori K, Misu K, et al. Painful alcoholic polyneuropathy with predominant small-fiber loss and normal thiamine status. Neurology. Jun 26 2001;56(12):1727-32. [Medline].

  8. Masaki T, Mochizuki H, Matsushita S, et al. Association of aldehyde dehydrogenase-2 polymorphism with alcoholic polyneuropathy in humans. Neurosci Lett. Jun 17 2004;363(3):288-90. [Medline].

  9. Avaria Mde L, Mills JL, Kleinsteuber K, et al. Peripheral nerve conduction abnormalities in children exposed to alcohol in utero. J Pediatr. Mar 2004;144(3):338-43. [Medline].

  10. Pessione F, Gerchstein JL, Rueff B. Parental history of alcoholism: a risk factor for alcohol-related peripheral neuropathies. Alcohol Alcohol. Nov 1995;30(6):749-54. [Medline].

  11. Ammendola A, Gemini D, Iannaccone S, et al. Gender and peripheral neuropathy in chronic alcoholism: a clinical-electroneurographic study. Alcohol Alcohol. Jul-Aug 2000;35(4):368-71. [Medline][Full Text].

  12. Peters TJ, Kotowicz J, Nyka W, et al. Treatment of alcoholic polyneuropathy with vitamin B complex: a randomised controlled trial. Alcohol Alcohol. Nov-Dec 2006;41(6):636-42. [Medline][Full Text].

  13. Fama R, Eisen JC, Rosenbloom MJ, et al. Upper and lower limb motor impairments in alcoholism, HIV infection, and their comorbidity. Alcohol Clin Exp Res. Jun 2007;31(6):1038-44. [Medline].

  14. Schott K, Schäfer G, Günthner A, et al. T-wave response: a sensitive test for latent alcoholic polyneuropathy. Addict Biol. Jul 2002;7(3):315-9. [Medline].

  15. Gane E, Bergman R, Hutchinson D. Resolution of alcoholic neuropathy following liver transplantation. Liver Transpl. Dec 2004;10(12):1545-8. [Medline][Full Text].

  16. Dell PC, Guzewicz RM. Atypical peripheral neuropathies. Hand Clin. May 1992;8(2):275-83. [Medline].

  17. Agelink MW, Malessa R, Weisser U, et al. Alcoholism, peripheral neuropathy (PNP) and cardiovascular autonomic neuropathy (CAN). J Neurol Sci. Dec 11 1998;161(2):135-42. [Medline].

  18. Bushbacher L. Rehabilitation of patients with peripheral neuropathies. In: Braddom RL, ed. Physical Medicine and Rehabilitation. Philadelphia, Pa: Saunders; 1995:984.

  19. Hilz MJ, Zimmermann P, Rösl G, et al. Vibrameter testing facilitates the diagnosis of uremic and alcoholic polyneuropathy. Acta Neurol Scand. Dec 1995;92(6):486-90. [Medline].

  20. Koike H, Sobue G. Alcoholic neuropathy. Curr Opin Neurol. Oct 2006;19(5):481-6. [Medline].

  21. Monforte R, Estruch R, Valls-Sole J, et al. Autonomic and peripheral neuropathies in patients with chronic alcoholism. A dose-related toxic effect of alcohol. Arch Neurol. Jan 1995;52(1):45-51. [Medline].

  22. Nishiyama K, Sakuta M. Mexiletine for painful alcoholic neuropathy. Internal Medicine. 1995, June;34(6):577-9. [Medline][Full Text].

  23. Oishi M, Mochizuki Y, Suzuki Y, et al. Current perception threshold and sympathetic skin response in diabetic and alcoholic polyneuropathies. Intern Med. Oct 2002;41(10):819-22. [Medline][Full Text].

  24. Scholz E, Diener HC, Dichgans J, et al. Incidence of peripheral neuropathy and cerebellar ataxia in chronic alcoholics. J Neurol. Aug 1986;233(4):212-7. [Medline].

Further Reading

Keywords

alcoholic neuropathy, alcohol neuropathy, peripheral neuropathy, alcoholism-induced neuropathy, alcohol-related neuropathy, primary axonal sensorimotor peripheral polyneuropathy, neuropathy treatment, axonal neuropathy, neuropathy pain, symptoms of neuropathy, nutritional axonal sensorimotor polyneuropathy, nutritional neuropathy, toxic axonal sensorimotor polyneuropathy, alcoholism, alcohol addiction

Contributor Information and Disclosures

Author

Scott R Laker, MD, Staff Physician, Department of Rehabilitation, University of Colorado Health Sciences Center
Scott R Laker, MD is a member of the following medical societies: American Academy of Physical Medicine and Rehabilitation
Disclosure: Nothing to disclose.

Coauthor(s)

William J Sullivan, MD, Assistant Professor, Pain Medicine Fellowship Director, Director of Medical Student Education, Department of Physical Medicine and Rehabilitation, University of Colorado at Denver Health Sciences Center
William J Sullivan, MD is a member of the following medical societies: American Academy of Physical Medicine and Rehabilitation, American College of Sports Medicine, International Spine Intervention Society, North American Spine Society, and Physiatric Association of Spine, Sports and Occupational Rehabilitation
Disclosure: Nothing to disclose.

Medical Editor

Daniel D Scott, MD, MA, BS, Associate Professor, Department of Physical Medicine and Rehabilitation, University of Colorado at Denver and Health Sciences Center
Daniel D Scott, MD, MA, BS is a member of the following medical societies: Alpha Omega Alpha, American Academy of Physical Medicine and Rehabilitation, American Association of Neuromuscular and Electrodiagnostic Medicine, American Paraplegia Society, Association of Academic Physiatrists, National Multiple Sclerosis Society, and Physiatric Association of Spine, Sports and Occupational Rehabilitation
Disclosure: Nothing to disclose.

Pharmacy Editor

Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: Nothing to disclose.

Managing Editor

Michael T Andary, MD, MS, Residency Program Director, Professor, Department of Physical Medicine and Rehabilitation, Michigan State University College of Osteopathic Medicine
Michael T Andary, MD, MS is a member of the following medical societies: American Academy of Physical Medicine and Rehabilitation, American Association of Neuromuscular and Electrodiagnostic Medicine, American Medical Association, and Association of Academic Physiatrists
Disclosure: allergan Honoraria Speaking and teaching

CME Editor

Kelly L Allen, MD, Consulting Staff, Department of Physical Medicine and Rehabilitation, Lourdes Regional Rehabilitation Center, Our Lady of Lourdes Medical Center
Disclosure: Nothing to disclose.

Chief Editor

Robert H Meier III, MD, Director, Amputee Services of America; Active Medical Staff, Presbyterian/St Luke's Hospital, Spalding Rehabilitation Hospital, Select Specialty Hospital; Consulting Staff, Kindred Hospital
Robert H Meier III, MD is a member of the following medical societies: American Academy of Physical Medicine and Rehabilitation and Association of Academic Physiatrists
Disclosure: Nothing to disclose.

RELATED EMEDICINE ARTICLES
 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.